INDICATIONS
- the necessity of local therapy for the airways, which appears together with the following diseases: Upper respiratory tract infections (Rhinitis, Pharyngitis, Laryngitis, Tracheitis) and the related complications (Rhinosinusitis, Laryngo tracheitis), acute and chronic bronchitis, bronchial asthma;
- Immune system reinforcement;
- Post-operative complicaitons prevention
THE DEVICE COMES EQUIPPED WITH
- Aerosol therapy unit (main unit)
- Power supply cord
- RF8 Plus nebulizer
- Child nasal prong
- Adults nasal prong
- Mouthpiece
- Soft Touch adult mask
- Soft Touch child mask
- Valve
- Air filter
- Connection tube
TECHNICAL DATA
| Voltage: | 230V~ 50Hz 140VA |
| Max pressure: | 2.6 ± 0.4 bar |
| Compressor air output: | 10 l/min approx |
| Sound level (at 1 m): | Approx. 57 dB (A) with open cover approx. 54 dB (A) with closed cover continuous |
| Dimensions (W)x(D)x(H): | 270 x 180 x 110 mm |
| Weight: | 1.7 kg |
RF8 NEBULIZER
| Medication minimum capacity [ml] |
Medication maximum capacity [ml] |
(1) Operating pressure [bar] |
(1) Delivery [ml/min] (approx) |
(2) MMAD [μm] |
(2) BREATHABLE FRACTIONS < 5 μm (FPF) % |
|||
| 2 | 8 | 1.15 | max 0.44 |
min 0.28 |
max 4.12 |
min 3.69 |
max 59.8 |
min 64.2 |
(1) Values measured according to Manufacturer’s internal procedure I29-P07.5 Delivery rate values can change depending on the patient’s respiratory capacity.
(2) In vitro testing certified by TÜV Rheinland LGA Products GmbH – Germany in compliance with the European Standard EN 13544-1 for nebulising systems. Further details available on request.
